Perseus Proteomics Inc. (4882.T)

JPY 610.0

(-0.65%)

Total Liabilities Summary of Perseus Proteomics Inc.

  • Perseus Proteomics Inc.'s latest annual total liabilities in 2023 was 295.46 Million JPY , up 73.7% from previous year.
  • Perseus Proteomics Inc.'s latest quarterly total liabilities in 2024 Q1 was 299.98 Million JPY , up 1.53% from previous quarter.
  • Perseus Proteomics Inc. reported annual total liabilities of 170.1 Million JPY in 2022, up 14.64% from previous year.
  • Perseus Proteomics Inc. reported annual total liabilities of 148.37 Million JPY in 2021, up 324.99% from previous year.
  • Perseus Proteomics Inc. reported quarterly total liabilities of 205.84 Million JPY for 2023 Q2, up 22.78% from previous quarter.
  • Perseus Proteomics Inc. reported quarterly total liabilities of 295.46 Million JPY for 2023 Q4, up 22.55% from previous quarter.

Annual Total Liabilities Chart of Perseus Proteomics Inc. (2023 - 2019)

Historical Annual Total Liabilities of Perseus Proteomics Inc. (2023 - 2019)

Year Total Liabilities Total Liabilities Growth
2023 295.46 Million JPY 73.7%
2022 170.1 Million JPY 14.64%
2021 148.37 Million JPY 324.99%
2020 34.91 Million JPY -25.18%
2019 46.66 Million JPY 0.0%

Peer Total Liabilities Comparison of Perseus Proteomics Inc.

Name Total Liabilities Total Liabilities Difference
Kyowa Kirin Co., Ltd. 189.52 Billion JPY 99.844%
Astellas Pharma Inc. 1973.61 Billion JPY 99.985%
Chugai Pharmaceutical Co., Ltd. 306.96 Billion JPY 99.904%
Ono Pharmaceutical Co., Ltd. 115.06 Billion JPY 99.743%
Santen Pharmaceutical Co., Ltd. 130.33 Billion JPY 99.773%
JCR Pharmaceuticals Co., Ltd. 45.74 Billion JPY 99.354%
Daiichi Sankyo Company, Limited 1763.11 Billion JPY 99.983%
Otsuka Holdings Co., Ltd. 924.92 Billion JPY 99.968%